rs560701504
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_021072.4(HCN1):āc.2227C>Gā(p.Pro743Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000447 in 1,612,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_021072.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HCN1 | NM_021072.4 | c.2227C>G | p.Pro743Ala | missense_variant | 8/8 | ENST00000303230.6 | NP_066550.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HCN1 | ENST00000303230.6 | c.2227C>G | p.Pro743Ala | missense_variant | 8/8 | 1 | NM_021072.4 | ENSP00000307342 | P2 | |
HCN1 | ENST00000673735.1 | c.*452C>G | 3_prime_UTR_variant | 9/9 | ENSP00000501107 | A2 | ||||
HCN1 | ENST00000637305.1 | n.1390C>G | non_coding_transcript_exon_variant | 7/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000365 AC: 9AN: 246586Hom.: 0 AF XY: 0.0000224 AC XY: 3AN XY: 133746
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1459852Hom.: 0 Cov.: 32 AF XY: 0.00000826 AC XY: 6AN XY: 726208
GnomAD4 genome AF: 0.000309 AC: 47AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74478
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Early infantile epileptic encephalopathy with suppression bursts Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 08, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at